🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07842744
Starting soon Observational

Multiple Sclerosis Severity and Caregiver Health Outcomes

NCT07842744 · tracked via the Priya Life Science Turkey tracker
Sponsor
Süleyman Korkusuz
Phase
Observational
Started
2026-10-20
Last updated
2026-09-25

Condition(s) studied

Multiple SclerosisCaregiver BurdenSleep QualityPhysical ActivityPsychological Stress

Study summary

This cross-sectional observational study aims to investigate the associations between multiple sclerosis (MS) severity and caregivers' sleep quality, physical activity, body awareness, perceived stress, and caregiver burden. A total of 68 caregivers of patients with MS will be recruited from Başkent University Hospital. MS severity will be assessed using the Expanded Disability Status Scale (EDSS), while caregiver health outcomes will be evaluated using validated questionnaires. The findings are expected to provide insight into the multidimensional impact of MS severity on caregiver health and well-being.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Being 18 years of age or older. * Providing regular care to an individual diagnosed with multiple sclerosis for at least six months. * Volunteering to participate in the study. Exclusion Criteria: * Having a cognitive impairment that prevents completion of the assessments. * Having a severe physical or psychiatric condition that may interfere with study assessments. * Being unable to complete the questionnaires.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Atılım University Ankara Turkey (Türkiye)

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07842744 on ClinicalTrials.gov ↗ ← All trials in Turkey